Dolomite Bio’s Nadia Instrument is helping researchers to gain a deeper understanding of motor neuron disease through the use of single nuclei RNA sequencing (sNuc-Seq). This automated, microfluidic droplet-based platform allows flexible encapsulation of up to eight samples in parallel in under 20 minutes, helping to accelerate studies and generate high quality data.
In his AGBT 2019 presentation, PacBio’s Jason Underwood shared results of a collaborative project using Dolomite Bio’s Nadia Instrument together with the PacBio Sequel System for single cell isoform sequencing.
Dolomite Bio has decided to transfer the µencapsulator system to their sister brand, Dolomite Microfluidics - an expert in microfluidic technology. This decision enables Dolomite Bio to have an enhanced commercial focus on their newest product range - the Nadia Product family.
Dolomite Bio, a leading provider of cutting-edge single cell technologies, today announced the launch of a new scRNA-Seq Reagent Kit to expand the Nadia Instrument portfolio. This convenient and cost-effective option is being showcased at the Advances in Genome Biology and Technology 2019 General Meeting (AGBT2019) – February 27th to March 2nd in Marco Island, Florida.
After careful consideration, Dolomite Bio have decided to discontinue the manufacture and sales of the scRNA-Seq modular system. Dolomite Bio will be accepting orders of the scRNA-Seq modular system up until 30th June 2019 and will supply parts to current users until 30th June 2024.